Literature DB >> 34054047

Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review.

Stephen A Schworer1, Olivia L Francis1, Steven M Johnson2, Benjamin D Smith3, Stuart H Gold4,5, Andrew B Smitherman4,5, Eveline Y Wu1,6.   

Abstract

Activated PI3 kinase delta syndrome (APDS) is a combined immunodeficiency characterized by recurrent sinopulmonary infections, increased risk of herpesvirus infections, lymphoproliferation, autoimmunity, and increased risk of lymphoid malignancies. Gain-of-function mutations in PIK3CD and PIK3R1 result in increased phosphoinositide-3-kinase-delta activity which causes hyperactivation of lymphocytes and abnormal development and activation of T and B cells. Cytopenias are the most common autoimmune process occurring in patients with APDS and typically occur as a later manifestation of the disease. Here we present a female patient with an early autoimmune hemolytic anemia, hepatosplenomegaly, and frequent infections presenting in infancy, followed by development of significant lymphadenopathy before her diagnosis with APDS type 1. She had significant improvement in her infectious history with immunoglobulin replacement, and control of autoimmune hemolytic anemia with initiation of sirolimus after her diagnosis with APDS type 1. We utilize this case to review the literature on APDS and present the novel finding of early-onset autoimmune disease in the setting of APDS. Autoimmune cytopenias are seen in many primary immunodeficiencies, and workup of autoimmune cytopenias in young patients should include evaluation for underlying immune disorder.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34054047      PMCID: PMC8542580          DOI: 10.1097/MPH.0000000000002214

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  31 in total

1.  Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry.

Authors:  Elizabeth J Feuille; Niloofar Anooshiravani; Kathleen E Sullivan; Ramsay L Fuleihan; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2017-10-28       Impact factor: 8.317

Review 2.  Warm Autoimmune Hemolytic Anemia.

Authors:  Robert A Brodsky
Journal:  N Engl J Med       Date:  2019-08-15       Impact factor: 91.245

Review 3.  T and B-cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity.

Authors:  Silvia Preite; Julio Gomez-Rodriguez; Jennifer L Cannons; Pamela L Schwartzberg
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

Review 4.  PI3K pathway defects leading to immunodeficiency and immune dysregulation.

Authors:  Cristiane J Nunes-Santos; Gulbu Uzel; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2019-05       Impact factor: 10.793

5.  Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

Authors:  Maria Elena Maccari; Hassan Abolhassani; Asghar Aghamohammadi; Alessandro Aiuti; Olga Aleinikova; Catherine Bangs; Safa Baris; Federica Barzaghi; Helen Baxendale; Matthew Buckland; Siobhan O Burns; Caterina Cancrini; Andrew Cant; Pascal Cathébras; Marina Cavazzana; Anita Chandra; Francesca Conti; Tanya Coulter; Lisa A Devlin; J David M Edgar; Saul Faust; Alain Fischer; Marina Garcia-Prat; Lennart Hammarström; Maximilian Heeg; Stephen Jolles; Elif Karakoc-Aydiner; Gerhard Kindle; Ayca Kiykim; Dinakantha Kumararatne; Bodo Grimbacher; Hilary Longhurst; Nizar Mahlaoui; Tomas Milota; Fernando Moreira; Despina Moshous; Anna Mukhina; Olaf Neth; Benedicte Neven; Alexandra Nieters; Peter Olbrich; Ahmet Ozen; Jana Pachlopnik Schmid; Capucine Picard; Seraina Prader; William Rae; Janine Reichenbach; Stephan Rusch; Sinisa Savic; Alessia Scarselli; Raphael Scheible; Anna Sediva; Svetlana O Sharapova; Anna Shcherbina; Mary Slatter; Pere Soler-Palacin; Aurelie Stanislas; Felipe Suarez; Francesca Tucci; Annette Uhlmann; Joris van Montfrans; Klaus Warnatz; Anthony Peter Williams; Phil Wood; Sven Kracker; Alison Mary Condliffe; Stephan Ehl
Journal:  Front Immunol       Date:  2018-03-16       Impact factor: 7.561

Review 6.  Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8+ T Cell Survival, Differentiation, and Function.

Authors:  Jennifer L Cannons; Silvia Preite; Senta M Kapnick; Gulbu Uzel; Pamela L Schwartzberg
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

7.  Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.

Authors:  Ivan Angulo; Oscar Vadas; Fabien Garçon; Edward Banham-Hall; Vincent Plagnol; Timothy R Leahy; Helen Baxendale; Tanya Coulter; James Curtis; Changxin Wu; Katherine Blake-Palmer; Olga Perisic; Deborah Smyth; Mailis Maes; Christine Fiddler; Jatinder Juss; Deirdre Cilliers; Gašper Markelj; Anita Chandra; George Farmer; Anna Kielkowska; Jonathan Clark; Sven Kracker; Marianne Debré; Capucine Picard; Isabelle Pellier; Nada Jabado; James A Morris; Gabriela Barcenas-Morales; Alain Fischer; Len Stephens; Phillip Hawkins; Jeffrey C Barrett; Mario Abinun; Menna Clatworthy; Anne Durandy; Rainer Doffinger; Edwin R Chilvers; Andrew J Cant; Dinakantha Kumararatne; Klaus Okkenhaug; Roger L Williams; Alison Condliffe; Sergey Nejentsev
Journal:  Science       Date:  2013-10-17       Impact factor: 47.728

8.  Autoimmune cytopenias in common variable immunodeficiency.

Authors:  Jenna C Podjasek; Roshini S Abraham
Journal:  Front Immunol       Date:  2012-07-24       Impact factor: 7.561

9.  Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

Authors:  Tanya I Coulter; Anita Chandra; Chris M Bacon; Judith Babar; James Curtis; Nick Screaton; John R Goodlad; George Farmer; Cathal Laurence Steele; Timothy Ronan Leahy; Rainer Doffinger; Helen Baxendale; Jolanta Bernatoniene; J David M Edgar; Hilary J Longhurst; Stephan Ehl; Carsten Speckmann; Bodo Grimbacher; Anna Sediva; Tomas Milota; Saul N Faust; Anthony P Williams; Grant Hayman; Zeynep Yesim Kucuk; Rosie Hague; Paul French; Richard Brooker; Peter Forsyth; Richard Herriot; Caterina Cancrini; Paolo Palma; Paola Ariganello; Niall Conlon; Conleth Feighery; Patrick J Gavin; Alison Jones; Kohsuke Imai; Mohammad A A Ibrahim; Gašper Markelj; Mario Abinun; Frédéric Rieux-Laucat; Sylvain Latour; Isabelle Pellier; Alain Fischer; Fabien Touzot; Jean-Laurent Casanova; Anne Durandy; Siobhan O Burns; Sinisa Savic; D S Kumararatne; Despina Moshous; Sven Kracker; Bart Vanhaesebroeck; Klaus Okkenhaug; Capucine Picard; Sergey Nejentsev; Alison M Condliffe; Andrew James Cant
Journal:  J Allergy Clin Immunol       Date:  2016-07-16       Impact factor: 10.793

Review 10.  The Treatment of Activated PI3Kδ Syndrome.

Authors:  Tanya I Coulter; Andrew J Cant
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

View more
  1 in total

Review 1.  Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.

Authors:  Sanchi Chawla; Prabal Barman; Rahul Tyagi; Ankur Kumar Jindal; Saniya Sharma; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.